Weight Loss Medications are administered via a weekly injection
In TRIUMPH-1, the first large Phase 3 trial (a large human trial with thousands of participants) in adults with obesity, retatrutide produced an average weight loss of 28.3% at the 12 mg dose after 80 weeks
With the same active ingredient tirzepatide they work the same way in your body and can have the same impact on your health
People in Princeton, Illinois, on tirzepatide should complement therapy with a balanced diet, regular activity, and consistent check-ins with their healthcare provider
By avoiding extreme heat, freezing temperatures, and direct light, you ensure that every injection provides the full clinical benefit intended to support your weight loss goals